Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV)

44Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The recent outbreak of severe acute respiratory syndrome (SARS), which is an acute respiratory illness, is caused by newly discovered SARS coronavirus (SARS-CoV). Herein we describe the antiviral activity of several classes of nucleoside analogues evaluated against SARS-CoV in Vero 76 cells, some of which exhibited moderate activity. ©2006 International Medical Press.

Cite

CITATION STYLE

APA

Chu, C. K., Gadthula, S., Chen, X., Choo, H., Olgen, S., Barnard, D. L., & Sidwell, R. W. (2006). Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV). Antiviral Chemistry and Chemotherapy, 17(5), 285–289. https://doi.org/10.1177/095632020601700506

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free